Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can smartphone apps help control type 2 diabetes? new study aims to find out.

NCT ID NCT07322757

Disease control Sponsor: Kuopio University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether two digital apps can help adults with type 2 diabetes who are at high risk for complications. About 120 participants will use the apps alongside standard care, while 50-100 others receive standard care alone. The study lasts 12 months and measures changes in weight, blood sugar, and other health markers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BitHabit digital application for behavioral lifestyle changes and Onnikka weight management digital application
What this could lead to
If successful, this could show that adding digital lifestyle apps to standard care helps people with type 2 diabetes better manage their weight, blood sugar, and overall health.
What could go wrong
This is a small, early-stage study with only 200 participants in one region of Finland. The results may not apply to everyone, and the apps may not lead to meaningful health improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 74 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Type 2 diabetes diagnosed * At least one of the following: 1. diagnosed coronary artery disease, 2. diagnosed periferal artery disease, 3. diagnosed heart failure, 4. diagnosed diabetic renal disease (GFR \<60 OR uACR ≥ 3 for at least three months), 5. diagnosed diabetic retinopathy, 6. previous stroke, 7. diagnosed atrial fibrillation or atrial flutter, 8. age ≥ 55 years and at least two of the following conditions: 1. smoker 2. uses antihypertensive medication or systolic blood pressure \>140 mmHg or diastolic blood pressure \> 80 mmHg, 3. uses lipid lowering medication or LDL-cholesterol \> 2.6 or 4. BMI \> 25 Exclusion Criteria: * eGFR \< 30 * uACR \> 200 * BMI \> 50 * heart ejection fraction EF \< 30 * active cancer or less than five years from cancer treatment at enrollment * blindness in both eyes * severe psychotic depression * inability to utilize digital applications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Wellbeing services county of North Savo, Nursing and Physician Services

    RECRUITING

    Kuopio, Northern Savonia, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.